Guidance, NICE advice and quality standards in development

Showing 11 to 20 of 370

Sort by

Guidance, NICE advice and quality standards in development
Title	Type	Expected publication date
ALXN1840 for treating Wilson disease TS ID 9950	Technology appraisal guidance	TBC
Alzheimer's disease (early) - gantenerumab [ID6142]	Technology appraisal guidance	TBC
Amyotrophic lateral sclerosis - SAR443820 [ID6386]	Technology appraisal guidance	TBC
Andexanet alfa for reversing anticoagulation in people with intracranial haemorrhage (part review of TA697) [ID6335]	Technology appraisal guidance	18 December 2024
Anhydrous sodium thiosulfate (Pedmarqsi) for preventing ototoxicity caused by cisplatin chemotherapy in people aged 1 month to 17 years with localised solid tumours [ID1001]	Technology appraisal guidance	TBC
Apalutamide with gonadotrophin-releasing hormone agonist and radiotherapy for treating high-risk, localised or locally advanced prostate cancer [ID6215]	Technology appraisal guidance	TBC
Arimoclomol for treating Niemann-Pick disease Type C [ID1312]	Highly specialised technology	TBC
Artificial intelligence software to help detect fractures in the emergency department (provisional title)	Health technology evaluation	17 December 2024
Artificial Intelligence technologies for assessing skin lesions selected for referral on the urgent suspected cancer pathway to detect benign lesions and reduce secondary care specialist appointments	Diagnostics guidance	TBC
Asthma: diagnosis, monitoring and chronic asthma management	NICE guideline	30 October 2024